D48.9
Conditions
Interventions
Group 1: Patients with a musculoskeletal tumor in the extremities, benign (before excision)
Group 2: Patients with a musculoskeletal tumor in the extremities, malign (before excision)
Sponsors
Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adult patients with a musculoskeletal tumor who are being treated surgically at the Heidelberg University Hospital are included in the study.
Exclusion criteria
Exclusion criteria: Age under 18 years • Inability to consent • Known intolerance to SonoVue® or other ultrasound contrast media. • Severe heart failure (NYHA III and IV), right-to-left shunt in the heart, uncontrollable high blood pressure. • Severe pulmonary disease, particularly severe obstructive pulmonary disease, ARDS and severe pulmonary arterial hypertension. • Myocardial infarction within the last 14 days. • Disorders of the galactose metabolism (galactosemia). • Pregnancy and breast feeding period. • Lack of informed consent or refusal to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The perfusion between benign and malignant soft tissue tumors differs significantly. | — |
Secondary
| Measure | Time frame |
|---|---|
| Different perfusion patterns can be determined in the area of ??the tumor mass and thus the biopsy planning can be improved. | — |
Countries
Germany
Contacts
Public ContactJulian Doll
Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie
Outcome results
None listed